’Live Nitrosamine Conversation’ Monday 14-Feb-22
Following ANVISA meeting this week to present final version of Nitrosamine Guidance, we are hosting our first ‘Live Nitrosamine Conversations’ to discuss perspectives and details of ANVISA’s presentation. @trust_user_a@trust_user_b
To guide us in this conversation, we have invited our community member Paulo Eliandro Silva from Integra Consultorio Farmaceutica. He will be presenting an overview of the guidance and sharing his perspectives from the recent meeting w/ ANVISA.
The ‘Live Nitrosamine Conversation’ will take place Feb 14th @ 8:00 AM (EST)
A big thank you to our community members who logged in for our very 1st ‘Live Nitrosamine Conversations’ … Despite some technical difficulties we were able to carry on a great discussion. A special acknowledgment to @PauloEliandro who guide us through the ANVISA’s updates and provided perspectives on what’s to come.
Paulo’s conversation presentation: Nitrosamine CP impact.pdf (2.5 MB) He also share his YouTube channel where he hosts discussions about Nitrosamines and provides regulatory perspectives.
Don’t miss the opportunity to ask questions to our guest speaker, he is a Nitrosamine reference beacon for the Brazil industry.